Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

Brain Research

Volumn 880, Issue 1-2, 2000, Pages 84-91

  O'Donnell, T ^a   Rotzinger, S ^a   Nakashima, T T ^a   Hanstock, C C ^a   Ulrich, M ^a   Silverstone, P H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Creatine; Inositol monophosphates; Lithium; Myo inositol; N acetylaspartate; Sodium valproate

Indexed keywords

AMPHETAMINE; CREATINE PHOSPHATE; INOSITOL; INOSITOL PHOSPHATE; LITHIUM; N ACETYLASPARTIC ACID; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0034644861     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02797-9     Document Type: Article

References (51)

1. Reduced brain inositol in lithium-treated rats
2. 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy
3. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
4. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain
5. A rapid method of total lipid extraction and purification
6. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
7. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro
8. Increase in AP-1 transcription factor DNA binding activity by valproic acid
9. Abnormal frontal lobe phosphorus metabolism in bipolar disorder
10. Decreased temporal lobe phosphomonoesters in bipolar disorder
11. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates
12. 1H magnetic resonance spectroscopic imaging
13. In vivo distribution of lithium in plasma and brain
14. Subacute and chronic in vivo lithium treatment inhibits agonist and fluoride-stimulated inositol phosphate production in rat cortex
15. 31P-NMR on developing dog brain
16. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
17. Cerebral lithium, inositol and inositol monophosphates
18. A gas chromatographic method for the determination of inositol monophosphates in rat brain
19. Chronic lithium treatment and status epilepticus induced by lithium and pilocarpine cause selective changes of amino acid concentrations in rat brain regions
20. 31P MRS
21. Brain phosphorus metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy
22. 7Li magnetic resonance spectroscopy
23. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy
24. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus
25. Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain
26. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids on rat brain regions and plasma
27. Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus
28. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications
29. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy
30. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C
31. Signal transduction pathways. Molecular targets for lithium's actions
32. Effects of dipropylacetate on the glycine clearance enzyme system and glycine levels
33. Lithium and bipolar disorder: CNS neurochemical changes associated with mood stabilization
34. Quantitative proton MRS in bipolar affective disorder: monitoring of lithium induced modulation of brain myo-inositol
35. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences
36. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with or without ischemic tolerance: an index of neuronal survival
37. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain
38. Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: a multinuclear magnetic resonance study in vivo
39. 31P-NMR spectra of cats receiving lithium chloride systemically
40. Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat
41. Effects of systematically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis
42. 31P MRS
43. 31P MRS
44. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes
45. Lithium effects on inositol phospholipids and inositol phosphates: evaluation of an in vivo model for assessing polyphosphoinositide turnover in brain
46. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate
47. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation
48. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers
49. Lithium stimulates gene expression through the AP-1 transcription factor pathway
50. 1H MR spectroscopy of children with bipolar disorder